Did you know?

Research Triangle Park, NC, USA and Cambridge, UK, 5 May 2021 -- Inivata, a leader in liquid biopsy, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused ...NIO Inc. American depositary shares, each representing one Class A ordinary share (NIO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.NeoGenomics, Inc. Common Stock (NEO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.The average Neogenomics stock price prediction forecasts a potential upside of 15.57% from the current NEO share price of $15.72. What is NEO's forecast return on assets (ROA) for 2023-2025? (NASDAQ: NEO) forecast ROA is -1.22%, which is lower than the forecast US Diagnostics & Research industry average of 15.95%.neither the cse, neo exchange, nasdaq nor its regulations services provider have reviewed or accept responsibility for the adequacy or accuracy of this release. PR Contact Vito Palmeri AMW PR c ...Dec 1, 2023 · NEO Earnings Date and Information. NeoGenomics last released its quarterly earnings data on November 6th, 2023. The medical research company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.11) by $0.05. The firm had revenue of $151.95 million for the quarter, compared to analyst estimates of ... If you purchased or acquired NeoGenomics securities, and/or would like to discuss your legal rights and options please visit NeoGenomics, Inc. Shareholder Class Action Lawsuit or contact Peter ...This page (NASDAQ:NEO) was last updated on. Best-in-Class Portfolio Monitoring. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get daily stock ideas from top-performing Wall Street …NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) was the target of unusually large options trading activity on Monday. Stock investors bought 3,696 call options on the company. This represents an increase of 695% compared to the average volume of 465 call options. Insider Buying and Selling In other NeoGenomics news, General Counsel Alicia C. Olivo […]About After Hours Quotes. Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $133.42 +6.25 4.91%. $137.87 +2.60 1.92% ...A share price of Neogenomics Inc. [NEO] is currently trading at $19.41, up 8.01%. It is a good measure of the stock's recent performance to check whether the stock's short-term value is rising or falling. The NEO shares have gain 23.16% over the last week, with a monthly amount glided 40.96%, and seem to beWhere NeoGenomics Stands With Analysts. Within the last quarter, NeoGenomics (NASDAQ:NEO) has observed the following analyst ratings: These 5 analysts have an average price target of $18.6 versus ...The company has a current ratio of 6.32, a quick ratio of 6.06 and a debt-to-equity ratio of 0.57. NeoGenomics, Inc. has a 12-month low of $8.70 and a 12-month high of $20.54. The firm has a 50 ...FORT MYERS, FL / ACCESSWIRE / November 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading oncology testing services company, today announced its third-quarter results for the ...Apr 28, 2021 · NasdaqCM:NEO Insider Trading Volume April 28th 2021 If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: insiders ... NeoGenomics, Inc. (NASDAQ:NEO) Q3 2023 Earnings Call Transcript Welcome to the NeoGenomics Third Quarter 2023 Earnings Call — Third Quarter 2023 Financial Results Conference Call and Webcast.Bridgewater Associates LP lessened its holdings in NeoGenomics,Graham Capital Management L.P. lessened its stake in sh NeoGenomics ( NASDAQ:NEO – Get Free Report) last announced its quarterly earnings data on Monday, November 6th. The medical research company reported ($0.06) earnings per share for the quarter ...Feb 21, 2023 · Those NASDAQ: NEO investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. On December 7, 2022, a lawsuit was filed against NeoGenomics ... As of April 6, 2023, the average one-year price target for NeoG Nasdaq Basic Canada is an accurate, cost-effective alternative for Canadian equities data via an API, operating Nasdaq CXC, CX2 & CXD and its three trading books. Learn more. Swiss National Bank raised its position in shares of NeoGenomics, Inc.

NeoGenomics, Inc. Common Stock (NEO) Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Charts Key Data Bid Price and Ask Price The bid & ask refers to the price that an...NeoGenomics, Inc. (NASDAQ:NEO) Q3 2023 Earnings Call Transcript Welcome to the NeoGenomics Third Quarter 2023 Earnings Call — Third Quarter 2023 Financial Results Conference Call and Webcast.As of October 5, 2023, the average one-year price target for Neogenomics is 21.61. The forecasts range from a low of 17.17 to a high of $27.30. The average price target represents an increase of ...NEO (NEO) prices - Nasdaq offers cryptocurrency prices & market activity data for US and global markets.

Phillips Edison & Company, Inc. Common Stock (PECO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Jan 24, 2022 · NasdaqCM:NEO Earnings Per Share Growth January 24th 2022 It's probably worth noting we've seen significant insider buying in the last quarter, which we consider a positive. …

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. NeoGenomics, Inc. (NASDAQ:NEO) Q4 2022 Earnings Call Transcript Febr. Possible cause: Nasdaq +74.49(+0.52%) Russell 2000 1,852.59 +43.57(+2.41%) Crude Oil -.